Table of Contents
Washington University Experience | NEOPLASMS (GLIAL) | Glioblastoma, adenoid pattern | 9C2 GBM, Adenoid (Case 9) GFAP 2.jpg
The majority of the tumor is strongly and nearly diffusely immunoreactive for GFAP which makes the unlabeled nodules stand out. (GFAP IHC)
